Intelligent Bio Solutions Initiates Validation Study for Rapid Drug Screening Cartridge Targeting 70% Faster Results
Intelligent Bio Solutions Inc. (Nasdaq: INBS) has initiated a validation study to reduce the analysis time of its Intelligent Fingerprinting Drug Screening System from ten minutes to under three minutes. This improvement aims to enhance its competitive position in the growing U.S. roadside drug testing market, projected to reach $1.62 billion by 20…